Interview: Jean Yves Gal – General Manager, Servier Morocco
13.05.2015
Related Interviews
Fadela Benjelloun – Executive Director, LEMM, Morocco
Fadela Benjelloun, executive director of LEMM, the association of multinational pharma companies in Morocco, explains the association’s key goals of improving access to healthcare and medicines, positioning Morocco as an…
Driss Chaoui – CEO, Afric-Phar, Morocco
Dr Driss Chaoui, CEO of Afric-Phar, one of the leading domestic companies in Moroccan pharma, provides insight into the major developments that have taken place at the company since we…
Sofia Lahlou – Country Manager, Versalya, Morocco
Sofia Lahlou, country manager for women’s and children’s health specialist Versalya in the Moroccan market, discusses the company’s formation, its therapeutic priorities, and the opportunities that exist for women in…
France / ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal; AntiVax Struggles; Servier’s Neurology Push
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its in-house product and the…
Oncology in Morocco / Access Challenges & New Solutions
Morocco has made admirable progress in building a national oncology network in recent years, but the country’s cancer patients still face significant challenges in terms of accessing the latest therapies.…
Manufacturing / Morocco: Becoming a Pharma Production Hub for Africa
Multinational pharmaceutical companies are increasingly seeing Morocco as a top manufacturing destination for the African continent. Firms from Europe, Asia-Pacific and the US are investing millions of dollars in bolstering…
Latest Report
